Display options
Share it on

Clin Rheumatol. 1985 Jun;4(2):183-8. doi: 10.1007/BF02032291.

Gold: hepatotoxic and cholestatic reactions.

Clinical rheumatology

A S Hanissian, B M Rothschild, S Kaplan

PMID: 3924468 DOI: 10.1007/BF02032291

Abstract

Gold hepatotoxicity is an uncommon but significant clinical problem. Hepatitis was first manifested one day to four weeks after the last dose of gold at a cumulative range of 35 to 2900 mg. An interesting dichotomy was noted between cholestatic and hepatotoxic reactions. Hepatotoxic reactions were associated with other clinical signs of hypersensitivity, thus facilitating differential diagnosis from viral hepatitis. Sudden clinical improvement in a patient receiving gold should stimulate evaluation for a hepatotoxic reaction.

References

  1. Arch Fr Pediatr. 1972 Dec;29(10 ):1097-106 - PubMed
  2. Ann Rheum Dis. 1974 Jan;33(1):25-31 - PubMed
  3. J Rheumatol. 1982 Sep-Oct;9(5):727-9 - PubMed
  4. Rev Rhum Mal Osteoartic. 1980 Mar;47(3):205 - PubMed
  5. Helv Med Acta. 1960 Dec;27:707-15 - PubMed
  6. Am J Pathol. 1961 Apr;38(4):411-36 - PubMed
  7. Blood. 1955 Jan;10(1):62-75 - PubMed
  8. J Rheumatol. 1974 Jun;1(2):187-9 - PubMed
  9. J Forensic Sci. 1966 Oct;11(4):441-73 - PubMed
  10. Arch Anat Cytol Pathol. 1981;29(2):98-104 - PubMed
  11. Ann Intern Med. 1977 Dec;87(6):717-9 - PubMed
  12. J Rheumatol. 1983 Jun;10(3):510-1 - PubMed
  13. Arch Intern Med. 1965 Feb;115:128-36 - PubMed
  14. Z Rheumaforsch. 1970 Jan-Feb;29(1):46-8 - PubMed
  15. Arthritis Rheum. 1984 Feb;27(2):230-2 - PubMed
  16. Rheumatol Rehabil. 1979 Aug;18(3):174-6 - PubMed

Substances

MeSH terms

Publication Types